Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$407.24
-3.3%
$422.91
$328.57
▼
$603.88
$141.17B1.452.43 million shs2.09 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-2.23%-6.36%-2.82%+12.41%-23.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$407.24
-3.3%
$422.91
$328.57
▼
$603.88
$141.17B1.452.43 million shs2.09 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-2.23%-6.36%-2.82%+12.41%-23.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.80
Moderate Buy$495.9021.77% Upside

Current Analyst Ratings Breakdown

Latest ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetBuy$454.00 ➝ $513.00
11/17/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOutperform
11/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
10/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
UpgradeHold ➝ Strong-Buy
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price TargetOutperform$473.00 ➝ $503.00
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOutperform$500.00
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$487.00 ➝ $486.00
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$485.00 ➝ $500.00
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOutperform$480.00
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetOverweight$450.00 ➝ $475.00
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$11.58B12.19$8.77 per share46.41$46.50 per share8.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2749.2439.162.9725.54%18.17%15.73%1/28/2027 (Estimated)

Latest ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/20/2026Q3 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.65$3.00+$0.35$1.49$2.91 billion$3.05 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
3.33
2.49

Institutional Ownership

CompanyInstitutional Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021346.64 million344.56 millionOptionable

Recent News About These Companies

Why Is Intuitive Surgical (ISRG) At The Center Of The Robotics Boom?
Is the Options Market Predicting a Spike in Intuitive Surgical Stock?
Could Intuitive Surgical Stock Turn $10,000 Into $12,200?
Should You Buy The Dip In Intuitive Surgical Stock?
What Makes Intuitive Surgical (ISRG) a Compelling Investment?
ISRG EPS Climbs 25% to $3: Is Innovation Driving Profitable Growth?
What Makes Intuitive Surgical (ISRG) a Compelling Investment?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$407.24 -13.71 (-3.26%)
Closing price 04:00 PM Eastern
Extended Trading
$404.96 -2.28 (-0.56%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.